Dynavax Technologies Corporation (DVAX) Social Stream
Dynavax Technologies Corp (DVAX) Price Targets From Analysts
Use the tables below to see what analysts covering Dynavax Technologies Corp think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
DVAX's average price target has moved up $11 over the prior 44 weeks.
DVAX reports an average of 83.88% for its upside potential over the past 48 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
DVAX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
DVAX's average broker recommendation rating improved by 0 over the prior 59 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Dynavax Technologies Corp fares relative to all US stocks, note that its number of analysts covering the stock is higher than 22.3% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, Dynavax Technologies Corp's upside potential (average analyst target price relative to current price) is greater than 175.22% of them.
- DVAX has a lower variance in analysts' estimates than 71.94% of Pharmaceutical Products stocks.
- In terms of how Dynavax Technologies Corp fares relative to stocks in the mid market cap category, note that its average analyst price target is greater than 63.21% of that group.
In the Pharmaceutical Products industry, DCPH, CYTK, and CYRX are the three stocks most similar to Dynavax Technologies Corp regarding the price target and analyst recommendation information presented here.
Is DVAX a Buy, Hold or Sell? See the POWR Ratings now!